Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Base-editing technologies along with AAV engineering not only help reduce costs but can also accelerate preclinical therapeutic development.

Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to ... wrestle with genetic redundancy and a lack of specificity in gene targeting. Here the authors develop a scalable CRISPR system ...

The eBook offers clear, accessible insights ... the guide demonstrates why CRISPR-Cas9 has become a foundational tool in genetic research. To learn how gene editing is shaping the future, download ...

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial. The Lancet ...

Collaborating with CRISPR-Cas9 co-inventor Jennifer Doudna and Jill Banfield at ... Our research team developed a miniature ...

However, there are concerns that cutting the wrong gene or cutting too many times could cause genetic damage or new cancers. Peer and his team developed a CRISPR-Cas9 'delivery system' that uses ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI ...